Research

A recent research study in the Journal of Nature Products showed that cannabis compounds prevented the COVID-19 virus from penetrating healthy human cells.

As cannabis becomes more accepted across the US, universities are realizing the potential to educate a new class of students eager to join the cannabis industry across many levels of employment. Saint Louis University has developed two online programs for their students to learn and engage with cannabis industry insiders and help set them up for potential careers in upon graduation. We recently spoke with Stacy Godlewski from Saint Louis University about how their programs were developed, what students can expect to learn, and more.

Yissum, the Technology Transfer Company at Hebrew University of Jerusalem as well as the university's Multidisciplinary Center for Cannabinoid Research (MCCR) recently announced a new partnership with TechforCann Europe Accelerator to strengthen the medical cannabis industry in Europe.

Recently The Hemp Mine, LLC announced their joint collaboration with Clemson University, to create the Cannabis Research Coalition (CRC).

Tetragram shares some anonymous user data to see a snapshot of real-world results for patients reporting symptoms of PTSD.

To date, clinical evidence supporting the efficacy of cannabis for PTSD has been positive in nature but weak in power; hopefully stronger clinical evidence will be forthcoming.

Gb Sciences, recently announced positive results from a study of its cannabinoid-containing mixtures as a potential treatment for cytokine release syndrome (CRS). With the high rate of transmission of the Omicron variant in multiple countries, Gb Sciences team are working to move quickly through the development stages for this novel CRS therapy.

The data presented here document the phytochemical composition of a large dataset of Group III cannabis cultivars and allow for the identification of distinct sub-classes.

Scientific research on breast cancer is still in its early stages, but here we take a look at what we have learned about cannabis to treat breast cancer thus far.

Better seed genetics, power-free tunable lighting, and other new scientific discoveries are making headway in what has become an ag-tech leading industry.

This study presents bioassays for CBD, which can be used to assess the neurotrophic bioactivity of CBD formulations.

David Heldreth, Founder and CEO of Panacea Plant Sciences, discusses the rise in interest in psychedelic medicine and more.

This study offers guidance to establishing meaningful quality standards for the commercialization of cannabis and cannabis-related products.

Here we take an in-depth exploration of the structure, function, and variation of cannabinoid receptor 1 (CB1R).

Dewey Scientific discovers the first powdery mildew resistant gene found in cannabis.

Cannabis’s biggest antagonist is the stigma that surrounds it. Whole plant medicine has the potential to significantly benefit the pharmaceutical industry by complementing their efforts to bring patients relief from their ailments. Systems dynamics consultant/researcher, Ruth Fisher, PhD, explains how cannabis has the option to flourish but needs to stop having its efforts for growth and research hampered by opinions.

An overview of the history regarding medical cannabis as a treatment option for epileptic disorders.

In this interview, Carl Esprey, CEO of Botanical Holdings speaks on the company’s path in the industry, the European cannabis industry and what the US can learn from other countries and more.

This technical piece is focused on the separation of the individual enantiomers of each compound mentioned above, as well as the combined separation of the compounds from each other for a fast, reliable quantification.

Dr. Marion McNabb has been conducting surveys related to medical cannabis for about five years and her most recent endeavor is to gauge the knowledge, interest, and understanding of medical cannabis in healthcare professionals. In this interview, she discusses her latest study as well as her background and key insights into the medical cannabis industry.

A systematic literature review to identify and compare analytical methods used for the determination of cannabinoids in different matrices using LC-based systems.

NFL-NFLPA Joint Pain Management Committee (PMC) plans to award up to $1 million in grants to CBD and cannabis researchers.

In this interview, Maria Enquist-Newman, PhD, Director of R&D Program Management at Demetrix, delves into the specifics of fermentation-produced cannabinoids and how this method can benefit the cannabis industry.

The Cannabis Center of Excellence, Inc., Medicinal Genomics, and UMass Dartmouth have established the Healthcare Provider Knowledge, Attitudes, Practices Related to Medical Cannabis Research Study to help better understand the experiences of healthcare providers have seen with medical cannabis.

Rebecca Jackson discusses a new program at the Maryland Medical Cannabis Commission (MMCC) and what they hope to achieve with it.